Form 4 for LAB STANDARD BIOTOOLS INC.

Accepted 2022-08-05 00:00:00 ET · period of report 2022-08-03 · accession 0000902664-22-003823 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2022-08-05	2022-08-03+	LAB	JOHNSON DAVID EDWARD	10%	P - Purchase	$1.75	+301.2K	11.44M	+3%	+$526.6K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, $0.001 par value per share ("Common Stock")	2022-08-03	P	A	46,009	$1.74	11,189,663	I See footnote	—	—	(F1) Price is the volume weighted average price of all trades by Caligan Partners LP ("Caligan") and David Johnson (together with Caligan, the "Reporting Persons") on the transaction date for prices ranging from $1.70 to $1.75. (F4) The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares traded at each separate price. (F3) The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.
2	Common	Common Stock	2022-08-04	P	A	255,173	$1.75	11,444,836	I See footnote	—	—	(F2) Price is the volume weighted average price of all trades by the Reporting Persons on the transaction date for prices ranging from $1.71 to $1.77. (F4) The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares traded at each separate price. (F3) The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.